TRVN Stock Summary and Trading Ideas (Trevena | NASDAQ:TRVN)

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Trevena trades on the NASDAQ stock market under the symbol TRVN.

As of April 18, 2024, TRVN stock price declined to $0.38 with 337,733 million shares trading.

TRVN has a beta of 0.26, meaning it tends to be less sensitive to market movements. TRVN has a correlation of 0.00 to the broad based SPY ETF.

TRVN has a market cap of $6.96 million. This is considered a Sub-Micro Cap stock.

Last quarter Trevena reported $-81,000 in Revenue and -$1.06 earnings per share. This fell short of revenue expectation by $-221,000 and missed earnings estimates by -$.68.

In the last 3 years, TRVN stock traded as high as $55.00 and as low as $.30.

The top ETF exchange traded funds that TRVN belongs to (by Net Assets): VXF.

TRVN has underperformed the market in the last year with a return of -49.3%, while the SPY ETF gained +23.1%. In the last 3 month period, TRVN fell short of the market, returning -44.5%, while SPY returned +6.8%. However, in the most recent 2 weeks TRVN has outperformed the stock market by returning +0.3%, while SPY returned -3.2%.

TRVN support price is $.38 and resistance is $.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TRVN stock will trade within this expected range on the day.